Literature DB >> 2427247

Biphasic contractions induced by milrinone at low temperature in ferret ventricular muscle: role of the sarcoplasmic reticulum and transmembrane calcium influx.

C O Malecot, D M Bers, B G Katzung.   

Abstract

The effects of milrinone were studied in ferret papillary muscle stimulated at various rates and temperatures from 23 degrees to 36 degrees C. In voltage-clamp experiments, 50 micrograms/ml (0.237 mM) milrinone induced a 2.1-fold increase in calcium current at 28 degrees or 36 degrees C. At 50 micrograms/ml, milrinone transiently increased contractility in all muscles at 28 degrees C, but its steady-state effect was either increased (+50%) or decreased (-24.7%) steady-state twitch amplitude. A negative inotropic effect always occurred below 27 degrees C. Milrinone decreased the total twitch duration and split the twitch into two components (P1 and P2) in the absence of any evidence of aberrant conduction. Increasing milrinone concentration from 50 to 300 micrograms/ml decreased P1 and increased P2. Ryanodine (100 mM) or caffeine (10 mM) suppressed P1. Contractions elicited after 30 seconds of rest were also biphasic in the presence of milrinone, but not in its absence. P2 of post-rest contraction was increased by caffeine or calcium (10 mM) and decreased by cobalt (2 mM) when drugs were applied at the beginning of the rest. Ryanodine and caffeine also suppressed P1 of post-rest contraction. The evidence suggests that P1 may be caused by Ca release from the sarcoplasmic reticulum and P2 by increased Ca influx during the action potential via the calcium channel. It is also suggested that P2 may be present under control conditions, but to a lesser extent, and masked by a large P1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427247     DOI: 10.1161/01.res.59.2.151

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

1.  Deformation of the Bowditch staircase in Ca(2+)-overloaded mammalian cardiac tissue--a calcium phenomenon?

Authors:  M Löhn; G Szymanski; F Markwardt
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Influence of ryanodine on the mechanical restitution and on the post-extrasystolic potentiation of the guinea-pig ventricular myocardium.

Authors:  G Oblonczek; G Szymanski
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

3.  Role of intracellular sodium in the regulation of intracellular calcium and contractility. Effects of DPI 201-106 on excitation-contraction coupling in human ventricular myocardium.

Authors:  J K Gwathmey; M T Slawsky; G M Briggs; J P Morgan
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 4.  Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.

Authors:  Chen Yan; Clint L Miller; Jun-ichi Abe
Journal:  Circ Res       Date:  2007-03-02       Impact factor: 17.367

Review 5.  Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.

Authors:  Clint L Miller; Chen Yan
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

Review 6.  Studies on the mechanism of action of the bipyridine milrinone on the heart.

Authors:  A E Farah; C J Frangakis
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

7.  Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.

Authors:  Delphine Mika; Pierre Bobin; Martine Pomérance; Patrick Lechêne; Ruth E Westenbroek; William A Catterall; Grégoire Vandecasteele; Jérôme Leroy; Rodolphe Fischmeister
Journal:  Cardiovasc Res       Date:  2013-08-09       Impact factor: 10.787

8.  Mechanisms of positive inotropic effects and delayed relaxation produced by DPI 201-106 in mammalian working myocardium: effects on intracellular calcium handling.

Authors:  Y Kihara; J K Gwathmey; W Grossman; J P Morgan
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

Review 9.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Authors:  Emily J Tsai; David A Kass
Journal:  Pharmacol Ther       Date:  2009-03-21       Impact factor: 12.310

10.  Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle.

Authors:  M Endoh; H Satoh; I Norota; K Hirano
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.